Status:

UNKNOWN

Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles)

Lead Sponsor:

aRigen Pharmaceuticals, Inc.

Conditions:

Herpes Zoster

Postherpetic Neuralgia

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

A multi-center, randomized, 4-arm, placebo-controlled, double-blind efficacy study of ARYS-01 (sorivudine) cream 3%.

Detailed Description

More than 95% of people are infected with varicella Zoster virus (VZV) at one time of life or another. Primary VZV infection manifests as varicella (chicken pox). The virus then establishes a latent i...

Eligibility Criteria

Inclusion

  • at least 18 years of age
  • diagnosed with herpes zoster
  • confirmed for VZV with lesion swab at screening and subsequent PCR test.
  • contraception for women of child-bearing potential
  • be able to communicate with investigator and compliant

Exclusion

  • cytotoxic or immunosuppressive drugs within 3 mos, 5-FU or its pro-drugs, tricyclic antidepressants, probenecid, topical or systemic antiviral drugs or immunomodulatory agents for viral infection
  • herpes zoster ophthalmicus
  • female patients who are pregnant and/or nursing or planning a pregnancy
  • congenital, acquired or corticosteroid-induced immunodeficiency, including malignancy
  • renal insufficiency or creatinine level \>2mg/dL
  • clinical significant liver enzyme abnormalities and any other laboratory abnormalities determined by the screening lab
  • history of intolerance or hypersensitivity to the cream components
  • current significant skin disease within affected dermatome
  • history of positive result for hepatitis B surface antigen, hepatitis C virus, or HIV
  • current participation in another clinical drug research study

Key Trial Info

Start Date :

March 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2009

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT00652184

Start Date

March 1 2008

End Date

September 1 2009

Last Update

October 7 2008

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

ARYS-0701 Site 3

Beverly Hills, California, United States, 90211

2

ARYS-0701 Site 6

Encino, California, United States, 91436

3

ARYS-0701 Site 7

Vista, California, United States, 92083

4

ARYS-0701 Site 8

Henderson, Nevada, United States, 89014